ELENBECESTAT
Elenbecestat is a BACE1 inhibitor reducing amyloid production for Alzheimers disease research. Side effects include headache, liver enzyme rise, and neuropsychiatric symptoms. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Elenbecestat is a potent BACE1 (site amyloid precursor proteincleaving enzyme 1) inhibitor designed to reduce production of amyloid peptides. By blocking the ratelimiting step in the amyloidogenic pathway, it lowers A40/42 formation and modulates neurodegenerative processes relevant to Alzheimer’s disease.
Benefits and Advantages
Used in amyloidpathway modelling, secretase inhibition assays, neurodegeneration research, and diseasemodifying therapeutic development.
Side Effects and Risks
Risks include liverenzyme elevations, headache, neuropsychiatric effects and potential offtarget protease interactions. Handle with CNSactive enzymeinhibitor precautions.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C19H18F3N5O2S |
|---|---|
| Molecular Weight | 437.4 g/mol |
| CAS Number | 1388651-30-6 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | Elenbecestat; 1388651-30-6; E-2609; E2609; RXJ96XL94H |
| IUPAC/Chemical Name | N-[3-[(4aS,5R,7aS)-2-amino-5-methyl-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-(difluoromethyl)pyrazine-2-carboxamide |
| InChl Key | AACUJFVOHGRMTR-DPXNYUHVSA-N |
| InChl Code | InChI=1S/C19H18F3N5O2S/c1-9-12-7-30-18(23)27-19(12,8-29-9)11-4-10(2-3-13(11)20)26-17(28)15-6-24-14(5-25-15)16(21)22/h2-6,9,12,16H,7-8H2,1H3,(H2,23,27)(H,26,28)/t9-,12-,19-/m1/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

